A University of Leeds study found a sharp increase in a rare autoimmune disease during the COVID-19 pandemic, primarily impacting previously unaffected groups. The study, which found a significant correlation with COVID-19 exposure, underscores the need for awareness and rapid treatment to mitigate severe outcomes like lung disease and death. Credit: SciTechDaily
Researchers discovered that during the DOI: 10.1016/j.ebiom.2024.105136
The data was generated by Dr Paula David and Dr Gabriele DeMarco from the University of Leeds’ School of Medicine and the Leeds Teaching Hospitals NHS Trust, with their Trust colleague Dr Khizer Iqbal.
Discussion about this post